Morenzo Abadi Perkasa Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Morenzo Abadi Perkasa Tbk. trades at Rp69 (market cap 147.05B, 8.6M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 76× Morenzo Abadi Perkasa Tbk.'s market cap, and Morenzo Abadi Perkasa Tbk. is more actively traded (8.6M versus 613K). Which is the better fit depends on your goals.
| ENZO | TSPC | |
|---|---|---|
Market Cap | 147.05B | 11.18T |
Volume | 8.6M | 613K |
Lot | 85.96K | 6.13K |
Turnover | 591.25M | 1.54B |
Average Price | 68.78 | 2,511.52 |
Value | 591.25M | 1.54B |
Indicative Equilibrium Price | 69 | 2,520 |
Indicative Equilibrium Volume | 4.14K | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Read more on ENZO →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →